This study will examine the safety and effectiveness of a bone marrow transplant after kidney transplant (from either a living or deceased donor). An investiga…

Kidney FailureKidney Transplant; ComplicationsChimera

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT05900401

Phase 1

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

To find the best method of administering NK cells in patients with recurrent glioblastoma.

Phase 1NK CellIL13Ra+4 more

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07579208